• SENSEX 73,123.83
    -125.56 (--0.17%)
  • BANKNIFTY 54,287.35
    -638.35 (--1.16%)
  • SBI
    950.75 900.80(%)
  • Tonbo Imaging
    1,209.85 1,209.85(%)
  • Cyient
    1,268.00 1,268.00(%)
  • NSE
    1,640.25 1,640.25(%)
  • Bonfiglioli Tran
    527.40 527.40(%)
  • IndusInd Bank
    831.35 750.45(%)
  • Eternal
    317.50 344.75(%)
  • JSW Energy
    440.25 428.00(%)
  • Voltas
    940.00 940.00(%)
  • Swiggy
    174.90 174.90(%)
  • Persistent Systems
    5,688.80 4,242.65(%)
  • Cupid
    302.45 45.40(%)
  • TCS
    2,624.75 3,336.70(%)
  • Infosys
    1,198.30 1,727.85(%)
  • Havells India
    1,003.65 1,003.65(%)
  • PC Jeweller
    17.08 7.45(%)
  • Bharat Forge
    1,680.45 1,265.00(%)
  • C P C L
    1,529.95 1,677.00(%)
  • Netweb Technol.
    4,238.00 2,942.45(%)
  • Lenskart Solut.
    615.80 355.70(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Biocon Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 14801.0
  • ISIN : INE376G01013
323.50 -7 (-2.06%)
  • As on 25 Oct 2026 (EOD)

  • Today’s Low

    318.40

  • Today’s High

    330.90

  • Open

    330.30

  • Perv Close

    330.30

  • 52W Low

    318.40

  • 52W High

    447.15

Key Indicators

  • P/E(TTM)

    176.54

  • Mar.Cap (₹Cr.)

    52,720.61

  • Div & Yield %

    0.15

  • Book Value(₹)

    167.99

  • Debt-Equity Ratio

    -2.06

  • AGM Date

    23-Oct-2026

  • EPS

    1.85

  • P/E Ratio

    176.54

Financials Ratios

  • Debt-Equity Ratio

    0.91

  • Mar.Cap (₹Cr.)

    52,720.61

  • RONW (%)

    6.89

  • ROCE (%)

    6.35

Score Board

  • Equity (₹ in Cr.)

    814.85

  • BV (₹)

    168.00

  • Sales( ₹ in Cr.)

    2,346.40

  • NP (in Cr.)

    175.30

  • NP Var(%)

    445.0

  • Div%

    10.0

  • CPS (₹)

    1.90

  • EPS (₹)

    1.10

  • Traded Value (₹ in Lakhs)

    53,225.81

  • 52 Week High

    447.15

  • 52 Week Low

    318.40

  • Price BSE

    327.0

  • Price NSE

    324.00

  • Market Capital( in Cr.)

    53,225.81

  • P/C Ratio

    170.50

  • P/E Ratio

    304.00

  • Price Vs.BV

    1.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 2,346.40 2,242.60 2,127.30 1,992.90 1,738.20 2,028.40
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 2,346.40 2,242.60 2,127.30 1,992.90 1,738.20 2,028.40
Other Income 319.70 849.80 207.50 3,134.20 187.20 150.20
Stock Adjustments 118.70 54.60 99.10 -3.20 105.80 -36.70
Total Income 2,784.80 3,147.00 2,433.90 5,123.90 2,031.20 2,141.90
EXPENDITURE :            
Raw Materials 1,187.60 1,085.40 1,033.80 981.00 914.00 761.60
Power and Fuel Cost 215.80 192.00 215.30 279.20 231.00 186.00
Employee Cost 467.20 501.30 452.30 433.80 367.70 390.20
Other Manufacturing Expenses 165.90 150.70 155.40 127.10 130.50 147.00
Selling and Administration Expenses 193.20 172.00 135.00 112.20 106.70 128.40
Miscellaneous Expenses 224.40 20.00 -28.10 32.90 33.00 66.00
Employee Benefit Expenses 467.20 501.30 452.30 433.80 367.70 390.20
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 2,454.10 2,121.40 1,963.70 1,966.20 1,782.90 1,679.20
Operating Profit 330.70 1,025.60 470.20 3,157.70 248.30 462.70
Interest 142.40 236.90 198.80 69.60 0.40 0.40
Gross Profit 188.30 788.70 271.40 3,088.10 247.90 462.30
Depreciation 137.30 127.80 121.10 116.90 108.20 103.50
Profit Before Tax 51.00 660.90 150.30 2,971.20 139.70 358.80
Current Tax 12.00 30.60 15.10 132.70 60.70 73.50
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 1.80 21.00 15.90 -9.90 -7.10 4.80
Reported Net Profit 37.20 609.30 119.30 2,848.40 86.10 280.50
Extraordinary Items -138.10 660.11 13.41 2,861.73 2.92 3.00
Adjusted Net Profit 175.30 -50.81 105.89 -13.33 83.18 277.50
Adjustment below Net Profit -23.50 -1.30 30.70 29.40 -59.40 30.40
P & L Balance brought forward 10,468.50 9,920.50 9,950.60 7,132.80 7,106.10 6,795.20
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 66.80 60.00 180.10 60.00 0.00 0.00
P & L Balance carried down 10,415.40 10,468.50 9,920.50 9,950.60 7,132.80 7,106.10
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 10.00 10.00 10.00 30.00 10.00 0.00
Dividend Per Share(Rs) 0.50 0.50 0.50 1.50 0.50 0.00
Earnings Per Share-Unit Curr 0.23 5.07 0.99 23.72 0.72 2.34
Earnings Per Share(Adj)-Unit Curr 0.23 5.07 0.99 23.72 0.72 2.34
Book Value 166.85 96.63 90.88 90.91 67.40 65.88
Book Value(Adj)-Unit Curr 166.85 96.63 90.88 90.91 67.40 65.88

Shareholding Pattern

  • Promoter Group

    44.68%

  • Public Share Holding

    55.14%

  • Custodian

    0.19%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 237,211,164 14.56 237,211,164 1
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 6,288,161 6,288,161.00 6,288,161 6,288,161
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 243,499,325 14.94 243,499,325 3
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 484,581,970 29.73 484,581,970 1
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 484,581,970 29.73 484,581,970 1
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 1,848,182 0.11 1,848,182 5
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 140,872,542 8.64 140,872,542 252
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 90,385,223 5.55 90,385,223 20
Mutual Funds / UTI 359,763,111 22.08 359,763,111 40
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 25,427,311 1.56 25,427,311 45
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 618,296,369 37.94 618,296,369 362
2] Non Institution
Bodies Corporate 85,301,218 5.23 85,301,218 1,796
Clearing Members 81,748 0.01 81,748 6
Directors of their Relatives 8,727,353 0.54 8,727,353 3
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 14,045,427 0.86 13,692,917 9,863
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 4,450,095 0.27 4,449,915 6,195
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 70,184,998 4.31 70,090,018 266
Individuals holding nominal share capital up to Rs. 1 lakh 95,907,164 5.89 95,898,733 374,529
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 504,948 0.03 504,948 21
Others 1,079,239 0.07 1,079,239 5
Sub Total 280,282,190 17.20 279,826,089 392,684
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 3,034,281 0.19 3,034,281 1
Total Shares held by Custodians and against which Depository Receipts have been issued 3,034,281 0.19 3,034,281 1
Grand Total ( A + B + C ) 1,629,694,135 100.00 1,629,238,034 393,051

Company Background

Biocon LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Biocon Ltd
  • BSE Code : 14801.0
  • ISIN : INE376G01013

  • Incorporation Year

    1978

  • Registered Office

    20th KM Hosur Road Hebbagodi
    Electronic City P O, Bangalore,
    Karnataka-560100

  • Telephone

    91-80-28082808

  • FAX

    91-80-28523423

  • Chairman

    Kiran Mazumdar Shaw

  • Managing Director

    Shreehas Pradeep Tambe

  • Company Secretary

    RAJESH UMAKANT SHANOY

  • Auditor

    B S R & Co LLP

  • Face Value

    5

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Biocon Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Biocon 326.60 2,666.10 2,346.40 544.33 1.61
Abbott India 25,004.30 7,217.19 6,929.05 32.91 43.78
Astrazeneca Phar 5,988.15 2,304.07 2,275.58 88.26 27.86
Glaxosmi. Pharma 2,404.80 3,932.76 3,790.20 38.42 58.17
Novartis India 1,834.75 393.10 354.33 46.33 15.94
Cipla 1,337.00 20,102.60 18,979.95 35.14 13.88
Bliss GVS Pharma 628.50 773.53 729.81 58.41 12.51
Amrutanjan Healt 487.65 520.13 502.55 26.12 24.16
Fermenta Biotec. 454.90 474.15 450.25 21.24 18.77
Guj. Themis Bio. 327.25 168.25 165.82 87.50 18.05
Ambalal Sarabhai 34.60 19.52 3.94 64.07 6.77